Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen L Goode

Showing results (211-220 of 315) with videos related to

Pageof 32
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survivalPeter Georgeson, Robert S Steinfelder, Tabitha A Harrison, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Cancer Causes & Control : CCC|March 5, 2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesMette T Faber, Susanne K Kjær, Christian Dehlendorff, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
International Journal of Cancer|July 27, 2016
Telomere structure and maintenance gene variants and risk of five cancer typesSara Karami, Younghun Han, Mala Pande, et al.
Pageof 32

Showing results (211-220 of 315) with videos related to

Sort By:
Pageof 32
Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survivalPeter Georgeson, Robert S Steinfelder, Tabitha A Harrison, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Cancer Causes & Control : CCC|March 5, 2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesMette T Faber, Susanne K Kjær, Christian Dehlendorff, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
International Journal of Cancer|July 27, 2016
Telomere structure and maintenance gene variants and risk of five cancer typesSara Karami, Younghun Han, Mala Pande, et al.
Pageof 32